The growth of atherosclerotic plaques in arteries that supply blood to organs, limbs, and the head causes peripheral vascular disorders (PVD). Peripheral artery occlusive disease (PAOD), peripheral artery disease (PAD), and peripheral obliterative arteriopathy are all terms used to describe this condition. It includes disorders of the peripheral veins and arteries, as well as diseases of the peripheral and cardiac circulation in the body. IVC filters, angiography catheters, EVAR stent-grafts, hemodynamic flow alteration, and plague modification devices are among the peripheral vascular devices used to treat peripheral arterial or coronary arterial disease, as well as in peripheral endovascular and coronary procedures. These devices are utilised to reduce patient interference while causing the least amount of disruption during the surgical operation.
Medtronic, Boston Scientific Corporation–are Notable Market Players in Peripheral Vascular Devices Market
The growth of the market is attributed to rising incidence of atherosclerosis, smoking, alcoholism, and obesity, coupled with the increasing prevalence of peripheral artery disease and arterial embolism drive the market growth. However, the high costs and complications associated with embolization procedures hampers the market growth.
Market leaders operating in the market have undertaken various organic and inorganic growth strategies. The peripheral vascular devices market majorly consists of players like Abbott, Edwards Lifesciences Corporation, Medtronic, Teleflex Incorporated, Boston Scientific Corporation, BD, Cook Medical LLC, Terumo Corporation, B. Braun Melsungen AG, and Cardinal Health Inc. among others.
Several in organic approaches, such as product launches, and expansion in the peripheral vascular devices, have resulted in the growth of the market. Likewise, inorganic strategies such as mergers & acquisitions, and collaboration have helped the company to strengthen its revenue, which allows the company to hold a strong position in the market.
Below is the list of the growth strategies done by the players operating in the peripheral vascular devices:
| Year | News |
|
Dec-2021 |
Terumo Corporation launched first commercial case of the Aortic Balloon in the United States. The device accommodates physicians in the expansion of the aorta when using TREO and RELAY stent-grafts in endovascular aortic repair. |
| Sep-2021 | Abbott acquired Walk Vascular, LLC to expand peripheral vascular offerings, and incorporate into Abbott’s existing endovascular product portfolio. Financial terms of the acquisition were not disclosed by the companies |
| Sep-2021 | Boston Scientific Corporation acquired California based Devoro Medical, Inc to expand its peripheral intervention product portfolio. Boston Scientific has been a strategic investor in Devoro Medical since 2019 and presently holds an equity stake of approximately 16%. As a result, the transaction consists of an upfront payment of approximately USD 269 million for the 84% stake not yet owned and up to USD 67 million upon achievement of certain clinical and regulatory achievement. |
| Oct-2021 | BD received 510(k) clearance for expanded indications from US FDA for the Rotarex Atherectomy System. The FDA clearance of the Rotarex Atherectomy System’s new inflated indications follows more than 10 years of real-world clinical experience involving the treatment of thousands of patients worldwide. |
